Dr Ricky Frazer
@rickyfrazer1.bsky.social
Consultant medical Oncologist, co-founder of ‘The Immunobuddies’ podcast, Deputy CEO of the Immuno-Oncology Clinical Network and perhaps most importantly a lover of Barrybados!
Happy holidays to all our Immunobuddies! Episode 173: Low Dose Immunotherapy with Dr Pablo Jimenez Royal Marsden- Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L) 1 inhibitor strategies @velindrecc.bsky.social @rickyfrazer1.bsky.social open.spotify.com/episode/3Ap1...
Episode 173: Low Dose Immunotherapy with Dr Pablo Jimenez Royal Marsden - Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L) 1 inhibitor strategies
open.spotify.com
Excited to announce our new 3-part podcast series on Personalised Immunotherapy! 📌 Episode 1: What does this mean? Featuring Dr. Paolo Ascierto, 🔗🎙️ Listen now: open.spotify.com/episode/3KAKYs… #Immunotherapy #PersonalisedMedicine #CancerCare #oncology
Curenetics Part 3 is now live! Can we apply AI to Toxicity Prediction, and how do we integrate this tool in the future? 🤖💉 Explore the potential of AI in predicting & managing toxicity in immunotherapy. Don’t miss it! 🎧✨ Listen here: open.spotify.com/episode/5qMOFx…
open.spotify.com
In the latest @immunobuddies Podcast, hosts @rickyfrazer1.bsky.social & @AOlssonBrown discuss the benefits of @EpiSwitchCiRT. Guests Drs Bartu Ahiska & Ryan Mathis explain how EpiSwitch CiRT tests the readiness of a #cancer patient’s immune system to work with #immunotherapy. buzzsprout.com/2128662
